Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin

NCT01330303 ·Status: COMPLETED ·Phase: PHASE1

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

NCT00379067 ·Status: COMPLETED ·Phase: PHASE4

Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)

NCT01454349 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

NCT00090103 ·Status: COMPLETED ·Phase: PHASE3

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

NCT00701779 ·Status: COMPLETED ·Phase: PHASE4

Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers

NCT02264184 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

NCT01673490 ·Status: TERMINATED ·Phase: PHASE4

Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients

NCT02244229 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

NCT02715024 ·Status: COMPLETED ·Phase: PHASE4

Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms

NCT02245490 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

NCT02827578 ·Status: UNKNOWN ·Phase: PHASE3

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

NCT01018511 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

NCT00970632 ·Status: COMPLETED ·Phase: PHASE3

Actual Use Study of Tamsulosin in Men

NCT02573311 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

NCT02862483 ·Status: UNKNOWN ·Phase: PHASE3

Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)

NCT00743184 ·Status: TERMINATED ·Phase: PHASE2

A Study of Tadalafil in Benign Prostatic Hyperplasia

NCT01183650 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

NCT05558007 ·Status: RECRUITING ·Phase: PHASE2

Real World Data on Management of Male LUTS

NCT03075449 ·Status: COMPLETED

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH

NCT01966614 ·Status: COMPLETED ·Phase: PHASE3

A Study in Benign Prostatic Hyperplasia

NCT01152190 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study

NCT06809205 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia

NCT02033798 ·Status: UNKNOWN ·Phase: NA

Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms

NCT02252367 ·Status: COMPLETED ·Phase: PHASE4

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

NCT02244294 ·Status: COMPLETED ·Phase: PHASE2